Dr. Samuel Washington III on work burden following prostate cancer treatment
“There are always other aspects of care other than that immediate treatment period that's needed,” says Samuel L. Washington III, MD.
Dr. Jani on the diagnostic yield of flotufolastat F 18 in men with low PSA levels
"Overall, we found that there was a high detection rate in patients with PSA less than 1 ng/mL," says Ashesh B. Jani, MD, MSEE, FASTRO.
Dr. Richards on exploring environmental risk factors in bladder cancer
“In the bladder cancer field, there's been a renewed shift on looking at environmental exposures,” says Kyle A. Richards, MD, FACS.
Dr. Hope provides an overview of guideline on 177Lu-PSMA-617 in prostate cancer
"We'll have to obviously amend this document quickly as these drugs move earlier in the stage of disease," says Thomas A. Hope, MD.
Cystectomy study underscores need for close communication between referring urologists, hospitals
"We're just trying to figure out ways to reduce our readmission rate, ways to reduce complications, and I think this is just a small step in doing that," says Randie White, MD.
Experts share what they are looking forward to at SMSNA Annual Meeting
“One of the things that the SMSNA does really well is promote, obviously, a lot of important learning, but also a lot of opportunities for networking,” says Matthew Ziegelmann, MD.
Dr. Richards on the effect of Agent Orange exposure on BCG treatment in NMIBC
“We wound up finding that there was no difference in recurrence, no difference in secondary events, and no difference in our survival end points whether or not you were exposed to Agent Orange,” says Kyle A. Richards, MD, FACS.
Dr. Randie White on travel distance and radical cystectomy outcomes
“I think one of the most interesting things that we found is that our readmission rate was about 40%,” says Randie White, MD.
Dr. Singhal discusses sexual and urinary function after radical prostatectomy
“It just gives us another piece of information that we can back up using data,” says Udit Singhal, MD.
Investigators evaluate impact of travel distance on radical cystectomy outcomes
“We wanted to look at, is there something to be said for delay in treatment or time to surgery?” says Randie White, MD.
New book written to inform patients, partners about prostate cancer
"It's one of the hopes that our colleagues will recommend this book to their patients and their partners, so now they have a knowledgeable patient," says Neil H. Baum, MD.
Dr. Siefker-Radtke highlights the latest erdafitinib research in urothelial carcinoma
"It is erdafitinib’s time to shine," says Arlene O. Siefker-Radtke, MD.
Dr. Kim shares his concerns with ProtecT trial interpretations
"I think what should be more appropriate is that the initial treatment decision does not impact [survival], but I don't think you can say that intervening aggressively for this lethal disease does not alter the course," says Isaac Y. Kim, MD, PhD, MBA.
Dr. Wallis on the importance of diversifying the surgical work force
“The better our health care work force represents the patients we're trying to take care of, the better care we'll deliver and the better outcomes our patients will have,” says Christopher J.D. Wallis, MD, PhD.
Dr. Randall Lee on next steps for value-based care framework in urology
“I think by applying these metrics that we've outlined in our manuscript, it's a perfect steppingstone in allowing urologists to take that step toward providing value-based care,” says Randall A. Lee, MD.
Dr. Schaeffer on how patient interactions helped inform prostate cancer book
“I've always felt like my patients are my partners in discovery,” says Edward M. Schaeffer, MD, PhD.
Investigators evaluate patient-reported functional outcomes after prostatectomy across eras
“With regards to urinary function, there were actually no differences between the 2 eras. We thought that was a little surprising,” says Udit Singhal, MD.
Dr. James Ferguson on future research needs for muscle-invasive bladder cancer
“At this point, we really have to consider the hard work and next steps of setting up multi-institutional databases and registries aimed at drilling down on patient and provider factors and medical decision-making around this diagnosis,” says James Ferguson III, MD, PhD.
Dr. Kavoussi discusses machine learning and AI-based tools’ roles in kidney stone treatment
“I think the key to remember for a lot of what we're doing is that kidney stone disease is complicated. It's a really heterogenous patient population,” says Nicholas L. Kavoussi, MD.
Urologists share the story behind their latest book
“So many times, partners were left in the dark. They didn't have a clue what their partner who had prostate cancer was going through, and we felt that we could fill that void,” says Neil H. Baum, MD.
Dr. Wallis discusses future work exploring surgeon gender and patient outcomes
“What we're thinking here is that surgeon sex is a surrogate for a whole series of behaviors driven by sociologic conditioning of how people interact with each other and how physicians practice medicine,” says Christopher J.D. Wallis, MD, PhD.
Investigators evaluate aggressive treatment rates for muscle-invasive bladder cancer
“We found that over 40% of patients with muscle-invasive bladder cancer are not receiving cystectomy or trimodal therapy,” says James Ferguson III, MD, PhD.
Expert explains surprising findings from value-based care research
“I think the other thing that was surprising was that this allowed us to really pinpoint where we were dragging our feet,” says Randall A. Lee, MD.
SMSNA board members preview this year’s meeting
“We have over 400 abstracts submitted this year to the SMSNA, which is really outstanding. We're looking at a record in terms of attendance this year, and we're very excited to have this,” says Mohit Khera, MD, MBA, MPH.
Dr. Singhal on understanding functional outcomes after radical prostatectomy
“The driving force for this was understanding whether we have made improvements as surgeons over time in how we're able to remove the prostate, but then also what types of functional outcomes patients have with regards to urinary function and sexual function,” says Udit Singhal, MD.
Experts on what the future holds for stone procedures
“There's going to be new techniques that we're not even aware of yet to try and break up the stones in a better fashion, but in a less invasive way for patients,” says Ben H. Chew, MD, MSc, FRCSC.
Study: Patients treated by female surgeons experience better postoperative outcomes
"Patients who have a female surgeon are about 25% less likely to die than if they had a male surgeon," says Christopher J.D. Wallis, MD, PhD.
Dr. Randall Lee on creating a value-based care framework
“As we increase spending, we know there are good data out there that we haven't seen reflective improvement in outcomes or decreasing complications when we treat our patients,” says Randall A. Lee, MD.
Dr. Chew and Dr. Bhojani on knowledge gaps related to intrarenal pressure
"We're currently doing a multicenter, prospective study using the new Boston Scientific scope to measure intrarenal pressure for every ureteroscopy that we perform to get more data and to be able to identify these patients earlier, before they get septic," says Naeem Bhojani, MD, FRCSC.
Experts discuss potential work with DEI content on urology residency websites
“Another effort could be querying recent applicants or current applicants and seeing what information about diversity, equity, and inclusion would be important to them,” says Keiko Cooley, MD.
2 Clarke Drive Cranbury, NJ 08512